- Poster Session
Posters 2: BPH

Saturday June 25, 2022 | 16:00 to 17:30
Room: Cedar & Elm

Learning Objectives

As a result of attending this session, participants will be able to:

  • Gain insight into current BPH treatment modalites and their outcomes
  • Recognize factors relevant to BPH/LUTS and its management
  • Identify areas for further scientific inquiry

 

Moderator


Presentations


16:30
MP-2.1

Ms. / Mme Claudia Deyirmendjian
Thulium fiber laser compared to holmium:YAG laser with Moses technology for enucleation of the prostate: a prospective study


16:34
MP-2.3

Dr. / Dr Ioana Fugaru
A Canadian population experience: total testosterone levels do not correlate with lower urinary tract symptom severity


16:38
MP-2.4

Dr. / Dr Alexandre Morin
Assessment of patient’s perceived stress and anxiety during day-case surgery for holmium laser enucleation of prostate


16:42
MP-2.5

Mr. / M. David-Dan Nguyen
Effect of surgeon volume and facility volume on outcomes of benign prostatic hyperplasia surgery


16:46
MP-2.6

Dr. / Dr Loay Abbas
Six-month outcomes in a cohort of patients undergoing same-day trial of void using standard versus MOSES HoLEP for BPH: a single-center experience


16:50
MP-2.7

Ms. / Mme Claudia Deyirmendjian
GreenLight photovaporization of the prostate in high-medical-risk patients: an analysis of the GlobalGreenLight Group (GGG) database


16:54
MP-2.9

Dr. / Dr Loay Abbas
Comparative analysis of MOSES technology versus novel Thulium Fiber Laser for transurethral enucleation of the prostate: a single institutional study


17:02
MP-2.11

Dr. / Dr Mark Assmus
Holmium laser enucleation of the prostate outcomes in neurologic disease states


17:06
MP-2.12

Dr. / Dr Brendan Lapointe Raizenne
Functional and surgical outcomes of aquablation in elderly men


17:10
MP-2.13

Dr. / Dr Loay Abbas
Emergency holmium laser enucleation of the prostate (HoLEP): a novel approach in the management of refractory hematuria of prostatic origin


17:14
MP-2.14

Dr. / Dr Mostafa M. Mostafa
Benign prostatic hyperplasia with voiding vs storage symptoms: a comparison of holmium laser enucleation of prostate outcomes



UP-2.3

Dr. / Dr Iman Sadri
Impact of 5-alpha reductase inhibitors on functional outcomes of greenlight photovaporization of the prostate (PVP): an analysis of 3500 men in the Global Greenlight Group (GGG) database



UP-2.4

Dr. / Dr Mostafa M. Mostafa
Improvement of overactive bladder symptoms: comparison between holmium laser enucleation of prostate, photo selective vaporization of the prostate and transurethral resection of prostate



UP-2.5

Dr. / Dr Dhanika Samaranayake
Perioperative antibiotics for transurethral resection of prostate in indwelling catheter dependence



UP-2.6

Ms. / Mme Claudia Deyirmendjian
Safety and efficacy of GreenLight PVP in octogenarians using the Global GreenLight Group database



UP-2.7

Dr. / Dr Mark Assmus
HoLEP outcomes after water vapor thermal therapy, prostatic urethral lift, robotic waterjet treatment or prostatic artery embolization



UP-2.8

Dr. / Dr Mark Assmus
Outcomes of concurrent bladder botox administration at the time of HoLEP: a feasibility evaluation



UP-2.9

Dr. / Dr Anthony-Joe Nassour
Safety and efficacy of the 980 nm diode system (EVOLVE laser prostatectomy) for the management of bothersome benign prostatic obstruction: An Australian experience




© 2024 CUA 77th Annual Meeting